Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb 8;115(2):220-221.
doi: 10.1093/jnci/djac211.

RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study

Holly J Pederson  1 , Stephanie S Faubion  2 , Sandhya Pruthi  3 , Shari Goldfarb  4   5
Affiliations
Comment

RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study

Holly J Pederson et al. J Natl Cancer Inst. .

Erratum in

No abstract available

PubMed Disclaimer

Comment in

  • Response to Pederson et al. and Chlebowski et al.
    Cold S, Cold F, Jensen MB, Cronin-Fenton D, Christiansen P, Ejlertsen B. Cold S, et al. J Natl Cancer Inst. 2023 Feb 8;115(2):229-230. doi: 10.1093/jnci/djac214. J Natl Cancer Inst. 2023. PMID: 36409030 Free PMC article. No abstract available.

Comment on

References

    1. Cold S, Cold F, Jensen M-B, Cronin-Fenton D, Christiansen P, Ejlertsen B.. Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study. JNCI J Natl Cancer Inst. 2022;114(10):1347-1354. doi:10.1093/jnci/djac112. - DOI - PMC - PubMed
    1. Bradley R, Braybrooke J, Gray R, et al.Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials. Lancet Oncol. 2021;22(8):1139-1150. doi:10.1016/S1470-2045(21)00288-6. - DOI - PMC - PubMed
    1. Baum M, Budzar AU, Cuzick J, et al.; ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002;359(9324):2131-2139. doi:10.1016/S0140-6736(02)09088-8. - DOI - PubMed
    1. Gradishar WJ, Moran MS, Abraham J, et al.Breast cancer, version 3.2022 NCCN categories of evidence and consensus. J Natl Compr Canc Netw. 2022;20(6):691-722. doi:10.6004/jnccn.2022.0030. - DOI - PubMed
    1. Yussof I, Mohd Tahir NA, Hatah E, Mohamed Shah N.. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast. 2022;62:22-35. doi:10.1016/j.breast.2022.01.012. - DOI - PMC - PubMed

LinkOut - more resources